Back
Unicycive Therapeutics, Inc. Stock Predictions
This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
42
UNCY
Unicycive Therapeutics, Inc.
Last Price:
$6.95
Seasonality Move:
-24.79%
7 Day Trial
ALL ACCESS PASS
$
7
Unicycive Therapeutics, Inc. Stock Forecast
-
Over the next 52 weeks, Unicycive Therapeutics, Inc. has on average historically risen by 0.6% based on the past 4 years of stock performance.
-
Unicycive Therapeutics, Inc. has risen higher in 2 of those 4 years over the subsequent 52-week period, corresponding to a historical accuracy of 50%
-
Is Unicycive Therapeutics, Inc. Stock Undervalued?The current Unicycive Therapeutics, Inc. [UNCY] share price is $6.93. The Score for UNCY is 42, which is 16% below its historic median score of 50, and infers higher risk than normal.
-
UNCY is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
Will Unicycive Therapeutics, Inc. Stock Go Up Next Year?
-
Over the next 52 weeks, Unicycive Therapeutics, Inc. has on average historically risen by 0.6% based on the past 4 years of stock performance.
Unicycive Therapeutics, Inc. Stock Rating
Sell
42
Unicycive Therapeutics, Inc. (UNCY)
is a Sell
Is Unicycive Therapeutics, Inc. overpriced?
-
Unicycive Therapeutics, Inc. has risen higher in 2 of those 4 years over the subsequent 52-week period, corresponding to a historical accuracy of 50%
Unicycive Therapeutics, Inc. Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
unicycive.com
52-Week Data
52-Week High:
11.00
52-Week Low:
3.71
Prediction Charts
Market Cap:
170.7M
Price in USD:
6.93
Volume:
487.6K
Beta:
1.84
Technical Analysis
SMA50:
6.69
SMA100:
6.28
SMA200:
5.46
52-Wk Change:
26.34%
Stock Predictions
-
Is Unicycive Therapeutics, Inc. stock public?Yes, Unicycive Therapeutics, Inc. is a publicly traded company.
-
What is the Unicycive Therapeutics, Inc. stock quote today?The Unicycive Therapeutics, Inc. stock price is 6.93 USD today.
-
How to buy Unicycive Therapeutics, Inc. stock online?You can buy Unicycive Therapeutics, Inc. shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
| Date | Opening | Closing | Minimum | Maximum |
|---|---|---|---|---|
| Mar-16 | 6.89 | 7.01 | 7.14 | 6.89 |
| Mar-17 | 7.03 | 6.98 | 7.09 | 6.86 |
| Mar-18 | 6.98 | 6.76 | 6.99 | 6.73 |
| Mar-19 | 6.80 | 6.81 | 6.89 | 6.61 |
| Mar-20 | 6.77 | 6.73 | 6.92 | 6.62 |
| Mar-23 | 6.88 | 6.77 | 6.91 | 6.69 |
| Mar-24 | 6.75 | 6.39 | 6.75 | 6.31 |
| Mar-25 | 6.51 | 6.65 | 6.87 | 6.48 |
| Mar-26 | 6.60 | 6.63 | 6.82 | 6.54 |
| Mar-27 | 6.57 | 6.39 | 6.61 | 6.25 |
| Mar-30 | 6.16 | 6.11 | 6.30 | 6.05 |
| Mar-31 | 6.22 | 6.58 | 6.65 | 6.20 |
| Apr-1 | 6.63 | 7.12 | 7.44 | 6.61 |
| Apr-2 | 6.95 | 6.93 | 7.08 | 6.77 |
Unicycive Therapeutics, Inc. Earnings
Unicycive Therapeutics, Inc. Earnings Report: Per Share Unicycive Therapeutics, Inc. Earnings Q1 Q2 Q3 and Q4 last year and next year.
Unicycive Therapeutics, Inc. Forecast Revenue Growth
Unicycive Therapeutics, Inc. Stock Analysis: Historical quarterly revenues per share for Unicycive Therapeutics, Inc. and historical quarterly revenue growth:
-
Analysts estimate an earnings increase this quarter of $0.78 per share, an increase next quarter of $4.47 per share, an increase this year of $2.72 per share, and an increase next year of $7.75 per share.
* Unicycive Therapeutics, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.